chr18-2614476-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006101.3(NDC80):c.1792-1961A>T variant causes a intron change. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0092 ( 3 hom., cov: 0)
Exomes 𝑓: 0.00088 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NDC80
NM_006101.3 intron
NM_006101.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
No conservation score assigned
Publications
1 publications found
Genes affected
NDC80 (HGNC:16909): (NDC80 kinetochore complex component) This gene encodes a component of the NDC80 kinetochore complex. The encoded protein consists of an N-terminal microtubule binding domain and a C-terminal coiled-coiled domain that interacts with other components of the complex. This protein functions to organize and stabilize microtubule-kinetochore interactions and is required for proper chromosome segregation. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BS2
High Homozygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00924 AC: 29AN: 3140Hom.: 3 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
29
AN:
3140
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00 AC: 0AN: 216 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
216
AF XY:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000879 AC: 1AN: 1138Hom.: 0 Cov.: 0 AF XY: 0.00136 AC XY: 1AN XY: 736 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1138
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
736
show subpopulations
African (AFR)
AF:
AC:
0
AN:
20
American (AMR)
AF:
AC:
0
AN:
40
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
28
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
88
European-Finnish (FIN)
AF:
AC:
0
AN:
94
Middle Eastern (MID)
AF:
AC:
0
AN:
6
European-Non Finnish (NFE)
AF:
AC:
1
AN:
812
Other (OTH)
AF:
AC:
0
AN:
50
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00922 AC: 29AN: 3144Hom.: 3 Cov.: 0 AF XY: 0.00772 AC XY: 11AN XY: 1424 show subpopulations
GnomAD4 genome
AF:
AC:
29
AN:
3144
Hom.:
Cov.:
0
AF XY:
AC XY:
11
AN XY:
1424
show subpopulations
African (AFR)
AF:
AC:
13
AN:
996
American (AMR)
AF:
AC:
4
AN:
212
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
58
East Asian (EAS)
AF:
AC:
0
AN:
50
South Asian (SAS)
AF:
AC:
0
AN:
42
European-Finnish (FIN)
AF:
AC:
0
AN:
134
Middle Eastern (MID)
AF:
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
AC:
11
AN:
1594
Other (OTH)
AF:
AC:
0
AN:
36
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.